Royalty Pharma poised for biggest US listing of this year
Royalty Pharma will sell $2.2bn of its shares in the biggest US initial public offering
Royalty Pharma will sell $2.2bn of its shares in the biggest US initial public offering
Convicted former drug company CEO Martin Shkreli, known as “Pharma Bro,” wants to get out
The result is a withering and encyclopedic indictment of a drug industry that often seems